Polymyalgia rheumatica and polymyalgia-like syndromes as adverse events following immunisation with COVID-19 vaccines: a 15 months update

Geahča maid

• Infective agents and polymyalgia rheumatica: key discussion points emerging from a narrative review of published literature
  Dahkki: Ciro Manzo, et al.
  Almmustuhtton: (2024-11-01)
• Did the first description of patients with polymyalgia rheumatica take place in Scotland or in Denmark?
  Dahkki: C. Manzo, et al.
  Almmustuhtton: (2024-03-01)
• Back to the future: identification and classification of polymyalgia rheumatica and polymyalgia rheumatica-like syndromes following cancer immunotherapy with checkpoint inhibitors
  Dahkki: Ciro Manzo, et al.
  Almmustuhtton: (2021-02-01)
• Identification and Classification of Polymyalgia Rheumatica (PMR) and PMR-Like Syndromes Following Immune Checkpoint Inhibitors (ICIs) Therapy: Discussion Points and Grey Areas Emerging from a Systematic Review of Published Literature
  Dahkki: Ciro Manzo, et al.
  Almmustuhtton: (2020-11-01)
• After what time interval are we justified to diagnose immune checkpoint inhibitor-mediated polymyalgia rheumatica?
  Dahkki: Ciro Manzo, et al.
  Almmustuhtton: (2025-03-01)